Table 2. Postoperative hypokalemia by demographic and clinical datas: univariate analysis.
| Variables | Patients (%) | Hypokalemia (%) | OR (95% CI) | P value |
|---|---|---|---|---|
| Sex | ||||
| Male | 76 (42.0) | 7 (9.2) | 1.00 | 0.881 |
| Female | 105 (58.0) | 9 (8.6) | 0.92 (0.33–2.60) | |
| Age | ||||
| ≤45 | 80 (44.2) | 6 (7.5) | 1.00 | 0.573 |
| >45 | 101 (55.8) | 10 (9.9) | 1.36 (0.47–3.90) | |
| Rural/urban geography | ||||
| Urban | 81 (44.8) | 3 (3.7) | 1.00 | 0.040 |
| Rural | 100 (55.2) | 13 (13.0) | 3.89 (1.07–14.14) | |
| Length of stay | ||||
| ≤12 days | 115 (63.5) | 6 (5.2) | 1.00 | 0.030 |
| >12 days | 66 (36.5) | 10 (15.2) | 3.24 (1.12–9.38) | |
| Hypertension | ||||
| No | 146 (80.7) | 8 (5.5) | 1.00 | 0.003 |
| Yes | 35 (19.3) | 8 (22.9) | 5.11 (1.76–14.80) | |
| Diabetes | ||||
| No | 162 (89.5) | 12 (7.4) | 1.00 | 0.059 |
| Yes | 19 (10.5) | 4 (21.1) | 3.33 (0.96–11.63) | |
| Tumor size | ||||
| ≤1.0 cm | 30 (16.6) | 2 (6.7) | 1.00 | 0.648 |
| >1.0cm | 151 (83.4) | 14 (9.3) | 1.43 (0.31–6.65) | |
| Type | ||||
| Nonfunctioning | 66 (36.5) | 2 (3.0) | 1.00 | 0.054 |
| Functioning | 115 (63.5) | 14 (12.2) | 4.44 (0.98–20.17) | |
| Type | ||||
| Non-PRL | 132 (72.9) | 14 (10.6) | 1.00 | 0.186 |
| PRL | 49 (27.1) | 2 (4.1) | 0.36 (0.08–1.64) | |
| Type | ||||
| Non-GH | 153 (84.5) | 14 (9.2) | 1.00 | 0.732 |
| GH | 28 (15.5) | 2 (7.1) | 0.76 (0.16–3.56) | |
| Type | ||||
| Non-ACTH | 165 (91.2) | 8 (4.8) | 1.00 | <0.001 |
| ACTH | 16 (8.8) | 8 (50.0) | 19.63 (5.82–65.84) | |
| Type | ||||
| Non-FSH | 172 (95.0) | 16 (9.3) | 1.00 | 0.722 |
| FSH | 9 (5.0) | 0 | – | |
| Type | ||||
| Non-TSH | 176 (97.2) | 15 (8.5) | 1.00 | 0.391 |
| TSH | 5 (2.8) | 1 (6.3) | 2.68 (0.28–25.57) | |
| Type | ||||
| Non-Mix | 173 (95.6) | 15 (8.7) | 1.00 | 0.711 |
| Mix | 8 (4.4) | 1 (12.5) | 1.51 (0.17–13.06) |